Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Serum lipidomic profiling as a useful tool for screening potential biomarkers of hepatitis B-related hepatocellular carcinoma by ultraperformance liquid chromatography–mass spectrometry (2015)

  • Authors:
  • USP affiliated authors: CARRILHO, FLAIR JOSÉ - FM
  • USP Schools: FM
  • DOI: 10.1186/s12885-015-1995-1
  • Subjects: TÉCNICAS DE DIAGNÓSTICO E PROCEDIMENTOS; CARCINOMA HEPATOCELULAR; BIOMARCADORES; HEPATITE B (COMPLICAÇÕES)
  • Language: Inglês
  • Imprenta:
  • Source:
    • Título do periódico: BMC Cancer
    • ISSN: 1471-2407
    • Volume/Número/Paginação/Ano: v. 15, n. art. 985, 9 p., 2015
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1186/s12885-015-1995-1 (Fonte: oaDOI API)
    • Este periódico é de acesso aberto
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: hybrid
    • Licença: cc-by
    Versões disponíveis em Acesso Aberto do: 10.1186/s12885-015-1995-1 (Fonte: Unpaywall API)

    Título do periódico: BMC Cancer

    ISSN: 1471-2407

    • Melhor URL em Acesso Aberto:


    • Outras alternativas de URLs em Acesso Aberto:


        • Página do artigo
        • Evidência: oa journal (via doaj)
        • Licença: cc-by
        • Versão: publishedVersion
        • Tipo de hospedagem: publisher




        • Página do artigo
        • Link para o PDF
        • Evidência: oa repository (via OAI-PMH title and first author match)
        • Licença: cc-by
        • Versão: publishedVersion
        • Tipo de hospedagem: repository


        • Página do artigo
        • Evidência: oa repository (via pmcid lookup)
        • Licença:
        • Versão: publishedVersion
        • Tipo de hospedagem: repository


    Informações sobre o Citescore
  • Título: BMC Cancer

    ISSN: 1471-2407

    Citescore - 2017: 3.49

    SJR - 2017: 1.464

    SNIP - 2017: 1.066


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM2757394-10BCSEP^163^2015
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      PASSOS-CASTILHO, Ana Maria; CARVALHO, Valdemir Melechco; CARDOZO, Karina Helena Morais; et al. Serum lipidomic profiling as a useful tool for screening potential biomarkers of hepatitis B-related hepatocellular carcinoma by ultraperformance liquid chromatography–mass spectrometry. BMC Cancer, London, v. 15, n. art. 985, p. 9 , 2015. Disponível em: < http://bmccancer.biomedcentral.com/articles/10.1186/s12885-015-1995-1 > DOI: 10.1186/s12885-015-1995-1.
    • APA

      Passos-Castilho, A. M., Carvalho, V. M., Cardozo, K. H. M., Kikuchi, L., Chagas, A. L., Gomes-Gouvêa, M. S., et al. (2015). Serum lipidomic profiling as a useful tool for screening potential biomarkers of hepatitis B-related hepatocellular carcinoma by ultraperformance liquid chromatography–mass spectrometry. BMC Cancer, 15( art. 985), 9 . doi:10.1186/s12885-015-1995-1
    • NLM

      Passos-Castilho AM, Carvalho VM, Cardozo KHM, Kikuchi L, Chagas AL, Gomes-Gouvêa MS, Malta F, Nastri AC de S-S, Pinho JRR, Carrilho FJ, Granato CFH. Serum lipidomic profiling as a useful tool for screening potential biomarkers of hepatitis B-related hepatocellular carcinoma by ultraperformance liquid chromatography–mass spectrometry [Internet]. BMC Cancer. 2015 ; 15( art. 985): 9 .Available from: http://bmccancer.biomedcentral.com/articles/10.1186/s12885-015-1995-1
    • Vancouver

      Passos-Castilho AM, Carvalho VM, Cardozo KHM, Kikuchi L, Chagas AL, Gomes-Gouvêa MS, Malta F, Nastri AC de S-S, Pinho JRR, Carrilho FJ, Granato CFH. Serum lipidomic profiling as a useful tool for screening potential biomarkers of hepatitis B-related hepatocellular carcinoma by ultraperformance liquid chromatography–mass spectrometry [Internet]. BMC Cancer. 2015 ; 15( art. 985): 9 .Available from: http://bmccancer.biomedcentral.com/articles/10.1186/s12885-015-1995-1

    Referências citadas na obra
    Ott JJ, Stevens GA, Groeger J, Wiersma ST. Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity. Vaccine. 2012;30:2212–9.
    Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010;127:2893–917.
    Carrilho FJ, Kikuchi L, Branco F, Gonçalves CS, Mattos AA, Brazilian HCC Study Group. Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil. Clinics (Sao Paulo). 2010;65:1285–90.
    European Association For The Study Of The Liver and European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908–43.
    McGlynn KA, Petrick JL, London WT. Global Epidemiology of Hepatocellular Carcinoma: An Emphasis on Demographic and Regional Variability. Clin Liver Dis. 2015;19:223–38.
    Bruix J, Sherman M. AASLD Practice Guideline. Management of hepatocellular carcinoma: an update. Hepatology. 2011;53:1020–2.
    Wenk MR. The emerging field of lipidomics. Nat Rev Drug Discov. 2005;4:594–610.
    Hu C, van der Heijden R, Wang M, van der Greef J, Hankemeier T, Xu G. Analytical strategies in lipidomics and applications in disease biomarker discovery. J Chromatogr B Analyt Technol Biomed Life Sci. 2009;877:2836–46.
    Diamond DL, Syder AJ, Jacobs JM, Sorensen CM, Walters KA, Proll SC, et al. Temporal Proteome and Lipidome Profiles Reveal Hepatitis C Virus-Associated Reprogramming of Hepatocellular Metabolism and Bioenergetics. PLoS Pathog. 2010;6:e1000719. doi: 10.1371/journal.ppat.1000719 .
    Patterson AD, Maurhofer O, Beyoglu D, Lanz C, Krausz KW, Pabst T, et al. Aberrant Lipid Metabolism in Hepatocellular Carcinoma Revealed by Plasma Metabolomics and Lipid Profiling. Cancer Res. 2011;71:6590–600.
    Wang B, Chen D, Chen Y, Hu Z, Cao M, Xie Q, et al. Metabonomic profiles discriminate hepatocellular carcinoma from liver cirrhosis by ultraperformance liquid chromatography-mass spectrometry. J Proteome Res. 2012;11:1217–27.
    Zhou L, Wang Q, Yin P, Xing W, Wu Z, Chen S, et al. Serum metabolomics reveals the deregulation of fatty acids metabolism in hepatocellular carcinoma and chronic liver diseases. Anal Bioanal Chem. 2012;403:203–13.
    Bligh EG, Dyer WJ. A rapid method of total lipid extraction and purification. Can J Biochem Physiol. 1959;37:911–7.
    Kimhofer T, Fye H, Taylor-Robinson S, Thursz M, Holmes E. Proteomic and metabonomic biomarkers for hepatocellular carcinoma: a comprehensive review. Br J Cancer. 2015;112:1141–56.
    Kim CK, Lim JH, Lee WJ. Detection of hepatocellular carcinomas and dysplastic nodules in cirrhotic liver: accuracy of ultrasonography in transplant patients. J Ultrasound Med. 2001;20:99–104.
    Bolondi L. Screening for hepatocellular carcinoma in cirrhosis. J Hepatol. 2003;39:1076–84.
    Singal A, Volk ML, Waljee A, Salgia R, Higgins P, Rogers MA, et al. Meta-analysis: surveillance with ultrasound for early-stage hepatocellular carcinoma in patients with cirrhosis. Aliment Pharmacol Ther. 2009;30:37–47.
    Kikuchi L, Chagas AL, Alencar RS, Paranaguá-Vezozzo DC, Carrilho FJ. Clinical and epidemiological aspects of hepatocellular carcinoma in Brazil. Antivir Ther. 2013;18:445–9.
    El-Serag HB. Hepatocellular carcinoma. N Engl J Med. 2011;365:1118–27.
    Sullentrop F, Moka D, Neubauer S, Haupt G, Engelmann U, Hahn J, et al. 31P NMR spectroscopy of blood plasma: determination and quantification of phospholipid classes in patients with renal cell carcinoma. NMR Biomed. 2002;15:60–8.
    Lewen Jia JC, Yin P, Lu X, Guowang X. Serum metabonomics study of chronic renal failure by ultra performance liquid chromatography coupled with Q-TOF mass spectrometry. Metabolomics. 2008;4:183–9.
    Oehler N, Volz T, Bhadra OD, Kah J, Allweiss L, Giersch K, et al. Binding of hepatitis B virus to its cellular receptor alters the expression profile of genes of bile acid metabolism. Hepatology. 2014;60:1483–93.